Comparing the Sunrise jaw‑movement wearable with oximetry and WatchPAT for diagnosing obstructive sleep apnoea
Official title: Sunrise in Obstructive Sleep Apnoea Study (SOSA) A Comparison of the Sunrise Mandibular Movement Monitoring Device With Overnight Oximetry and WatchPAT in the Diagnosis and Management of Obstructive Sleep Apnoea.
Run by Manchester Metropolitan University · NCT07269483 · Data updated 2026-11-12
This will test whether the Sunrise jaw‑movement wearable can help diagnose obstructive sleep apnoea in adults referred to an NHS sleep clinic by comparing it with overnight oximetry or the WatchPAT device.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Manchester Metropolitan University Academic / other |
| Locations | 1 site (Bristol, South West) |
| Status | Recruiting |
| Started | July 28, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | December 19, 2025 |
| Trial ID | NCT07269483 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) referred with suspected obstructive sleep apnoea who can give informed consent, have a smartphone with Bluetooth/WiFi to run the Sunrise app, and can follow English or picture‑guided instructions are eligible.
✕Probably not a fit
Patients with suspected non‑OSA sleep disorders, chronic hypercapnic respiratory failure, unstable cardiovascular disease, non‑arteritic anterior ischaemic optic neuropathy, or those without smartphone/internet access are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults referred with suspected obstructive sleep apnoea will use the Sunrise jaw‑movement wearable at home for one night at the same time as their usual diagnostic test (overnight oximetry or WatchPAT 300). Researchers will compare how often the different tests lead to a definitive management decision (start treatment, discharge, need more testing, or schedule a clinic appointment), plus time to decision and patient experience. The device has prior validation against full polysomnography with reported high accuracy, and this study embeds the device into an existing NHS diagnostic pathway to test real‑world performance. The study also seeks to include patients of diverse ethnic backgrounds to address gaps noted in guidance about device accuracy across skin tones.
Why it matters
Potential benefit: If successful, Sunrise could speed up and simplify home testing for OSA, leading to faster treatment decisions and a better patient experience.
How similar studies have gone: Previous validation studies comparing Sunrise to full polysomnography reported around 88–100% accuracy depending on severity and a 92% accuracy in one comparison, so the device has supportive evidence though pathway integration is less studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Adults (aged ≥18 years old) referred with suspected Obstructive Sleep Apnoea * Patient has capacity to provide informed consent * Patient has access to a smartphone with Bluetooth and WiFi or internet data to download the Sunrise app and to transmit the Sunrise results to the Sunrise portal. UHBW Trust Wi-Fi available to the patient at equipment collection and return if needed. * Willing and able to comply with the study-specific procedures * Ability to read and comprehend English or understand simple device user instructions with guided pictures in English. Exclusion Criteria: * • Suspected diagnosis of a sleep disorder other than OSA (including central sleep apnoea, parasomnias, narcolepsy, idiopathic hypersomnia) * Suspected chronic hypercapnic respiratory failure (history of acute hypercapnic respiratory failure, raised CO2 or serum bicarbonate) * Patients with unstable cardiovascular disease or non-arteritic anterior ischaemic optic neuropathy * Patients with beards who are unwilling to shave the area below their lip (the soul patch) * Patients with conditions affecting the rotation of the condyle in the temporo-mandibular joint * Unable to consent or lacks capacity to provide informed consent * In-patient referrals * Unwilling or unable to comply with the study-specific procedures. * Patients who have requested in their medical notes not to be involved in research or not to receive digital communication
Where it's running
-
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, South West, United Kingdom Recruiting
Study contacts
- Study coordinator: Rachel E Pickersgill, BSc
- Email: rachel.pickersgill@uhbw.nhs.uk
- Phone: +44(0)117923 0000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NNC0487-0111 for weight loss and sleep apnea in adults with obesity and OSA on PAP
A phase 3 study will test whether the medicine NNC0487-0111 helps adults who are overweight or have obesity and treated sleep apnea lose weight and improve sleep apnea symptoms compared with placebo.
-
Amazing weight loss and sleep apnea treatment with NNC0487-0111
This study tests whether weekly injections of NNC0487-0111 help adults with overweight or obesity and sleep apnea who aren’t using CPAP to lose weight and improve breathing during sleep.
-
F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
-
Sleep apnea biomarkers and CPAP use after diagnosis
This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.
-
Using the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
This real-world study tests whether the PLATO questionnaire can be feasibly used in dental sleep clinics for patients receiving oral appliance therapy for obstructive sleep apnea.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.